This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Johnson JA . Pharmacogenetics: Potential for individualized drug therapy through genetics. Trends Genet 2003; 19 (11): 660–666.
Nebert DW, Bingham E . Pharmacogenomics, out of the lab and into the community. Trends Biotechnol 2001; 19 (12): 519–523.
Roses AD . Pharmacogenetics and the practice of medicine. Nature 2000; 405: 857–865.
Weinshilboum R, Wang L . Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 2004; 3: 739–748.
Piccart MJ, Cardoso F . Progress in systemic therapy for breast cancer: and overview and perspectives. Eur J Cancer 2003; 1 (2): 56–69.
Hedgecoe A . The Politics of Personalized Medicine? Pharmacogenetics in the Clinic. Cambridge Studies in Society and the Life Sciences. Cambridge University press: Cambridge, 2004.
Weinshilboum R, Sladek S . Mercaptopurine pharmacogenetics: monogenetic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651–652.
Leyland-Jones B . Trastuzumab: hopes and realities. Lancet Oncol 2002; 3: 137–144.
Stefan C, Walsh W, Banka T, Adeli K, Verjee Z . Improved HPLC methodology for monitoring thiopurine metabolites in patients on thiopurine therapy. Clin Biochem 2004; 37 (9): 764–771.
Rokea A . Azathioprine: Current status and future considerations. Int J of Dermatology 2003; 43: 335–341.
Life Sciences and technology in health and agro-food (LIFETECH). (online) 2005. Available from URL: http://www.jrc.es/home/pages/action_4112.htm (cited 2005 March 30).
Isaacson Barash C . Role of the laboratory in leveraging adoption of pharmacogenetics. Am Clin Lab 2001; 20: 35–37.
Gurwitz DA, Weizman M, Rehavi M . Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends in Pharm Sci 2003; 24: 122–125.
Gaskell G, Allum N, Stares S . Europeans and biotechnology in 2002. Eurobarometer 58 [online] 2002. Available from URL: http://europa.eu.int/comm/public_opinion/archives/ebs/ebs_177_en.pdf [cited 2005 Mar 30].
Marshall E . Preventing toxicity with a gene test. Science 2003; 302: 588–590.
Rothstein MA, Epps PG . Ethical and legal implications of pharmacogenomics. Nat Rev Genet 2001; 2 (3): 228–231.
Ibarreta D, Elles R, Cassiman JJ, Rodriguez-Cerezo E, Dequeker E . Towards quality assurance and harmonization of genetic testing services in the European Union. Nat Biotechnol 2004; 22: 1230–1235.
Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC . HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol 2004; 22 (5): 854–863.
Veenstra DL, Higashi MK . Assessing the cost-effectiveness of pharmacogenomics. AAPS Pharmsci 2000; 2 (3): 1–11.
Acknowledgements
We are extremely grateful to Sibylle Gaisser from ISI Fraunhofer (Germany), Christien Enzing from TNO-STB (The Netherlands) and Jim Ryan from CIRCA group (Ireland) and their colleagues for producing the mailing lists for the survey in their respective countries.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woelderink, A., Ibarreta, D., Hopkins, M. et al. The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. Pharmacogenomics J 6, 3–7 (2006). https://doi.org/10.1038/sj.tpj.6500341
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500341
This article is cited by
-
A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance
Applied Health Economics and Health Policy (2020)
-
Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge
International Journal of Clinical Pharmacy (2019)
-
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Pharmaceutical Research (2017)
-
Pharmacogenetics and the print media: what is the public told?
BMC Medical Genetics (2015)
-
Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia
The Pharmacogenomics Journal (2014)